Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

Unique Challenges in Compounding: Managing Severe Musculoskeletal Pain in a Recovered Substance Abuser

Author(s):  Christiansen Joel, White Lyndell

Issue:  Jul/Aug 2010 - Sterile Compounding
View All Articles in Issue

Page(s):  310-314

Unique Challenges in Compounding: Managing Severe Musculoskeletal Pain in a Recovered Substance Abuser Page 1
Unique Challenges in Compounding: Managing Severe Musculoskeletal Pain in a Recovered Substance Abuser Page 2
Unique Challenges in Compounding: Managing Severe Musculoskeletal Pain in a Recovered Substance Abuser Page 3
Unique Challenges in Compounding: Managing Severe Musculoskeletal Pain in a Recovered Substance Abuser Page 4
Unique Challenges in Compounding: Managing Severe Musculoskeletal Pain in a Recovered Substance Abuser Page 5

Download in electronic PDF format for $65

Abstract:  Compounding pharmacists can provide a great therapeutic service to pain management patients who have overcome an addiction to prescribed or illegal drugs or alcohol. By collaborating with the physician and the patient, the compounder can develop an effective analgesic formulation with no addictive potential; a preparation that can be safely adjusted to meet changing medical needs. In this report, we present a personal account of the value of two compounded preparations that relieve severe musculoskeletal pain without producing mood-altering effects, as well as information about how those compounds are prepared.

Related Keywords: Joel Christiansen, EdS, Lyndell White, PharmD, RP, pain control, substance abuse, drug addicts, addiction recovery, analgesic, analgesia, formulation, muscle pain, ketoprofen, lidocaine, cyclobenzaprine hydrochloride, topical preparations, transdermal administration

Related Categories: FORMULATIONS, MENTAL HEALTH, PAIN MANAGEMENT, DOSAGE FORMS/DRUG CARRIERS, MUSCULOSKELETAL DISORDERS

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Unique Challenges in Compounding: Managing Severe Musculoskeletal Pain in a Recovered Substance Abuser
Christiansen Joel
, White Lyndell
Jul/Aug 2010
Pg. 310-314

Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome
Brown Scott
, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III
May/Jun 2010
Pg. 182-192

Veterinary Transdermal Medications: A to Z
Davidson Gigi S
Mar/Apr 2003
Pg. 106-113

Topical Medications for Orofacial Neuropathic Pain
Bramwell Bethany L
May/Jun 2010
Pg. 200-203

Efficacy and Clinical Value of Commonly Used Ingredients in Pain Management Compounds: A Literature Review
Beshay Sarah M
, Rivera Gerard, Balthasar Jan, Florea Naomi
Jul/Aug 2015
Pg. 295-300

Managing Pain with Transdermal Ketoprofen
Williams KaCee D
May/Jun 2010
Pg. 204-206

Skin Permeation and Antinociception of Compounded Topical Cyclobenzaprine Hydrochloride Formulations
Bryson Evan
, Hartman Rachel, Arnold John, Gorman Greg, Sweitzer Sarah.Asbill Scott
Mar/Apr 2015
Pg. 161-166

Ketoprofen 10%, Baclofen 2%, Cyclobenzaprine Hydrochloride 2%, Lidocaine 2% in Lipopen Ultra Cream Base
Allen Loyd V Jr
May/Jun 2017
Pg. 234

Compounded Pain Formulations: What is the Evidence?
Asbill Scott
, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso
Jul/Aug 2014
Pg. 278-286

Ketoprofen 5% and Lidocaine Hydrochloride 0.5% Topical Gel
Allen Loyd V Jr
Nov/Dec 2010
Pg. 520

Particle Measuring Systems - USP <797> Environmental Monitoring Solutions